Viking Therapeutics, Inc. (VKTX) stock
VKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$26.17−0.71 (-2.64%)
Close on Nov 18, 2026Market cap $3.34BP/E –Yield –
Viking Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Viking Therapeutics's price to book ratio was 8.1× on Nov 11, 2026, against 5.8× a year earlier. Over the last 5 years it ranged from 0.9× to 23.6×, with a median of 5.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 8.1× | +2.6 |
| 2025 | Dec 31, 2025 | 5.5× | +0.6 |
| 2024 | Dec 31, 2024 | 4.9× | −0.1 |
| 2023 | Dec 29, 2023 | 5.1× | +0.3 |
| 2022 | Dec 30, 2022 | 4.8× | +3.1 |
| 2021 | Dec 31, 2021 | 1.7× | +0.1 |
| 2020 | Dec 31, 2020 | 1.6× | −0.4 |
| 2019 | Dec 31, 2019 | 2.0× | +0.2 |
| 2018 | Dec 31, 2018 | 1.8× | −50.2 |
| 2017 | Dec 29, 2017 | 52.0× | +49.7 |
| 2016 | Dec 30, 2016 | 2.3× | −0.2 |
| 2015 | Dec 31, 2015 | 2.5× | – |
See a number that looks wrong?